Meta Platforms (NASDAQ:META) stock just earned a strong endorsement from UBS, which raised its price target on shares from $872 to $908 while maintaining a Buy rating. The firm’s bull thesis centers on continued GenAI-driven ad revenue growth and expected upward EPS and valuation revisions through 2026. For long-term investors, the revised target signals that ... UBS Hikes Meta Platforms’ Target From $872 to $908: Is the GenAI Ad Revenue Machine Just Warming Up?

More News

Crypto

European investors may switch banks for better crypto access, survey finds

CointelegraphApr 21, 2026

A survey by Börse Stuttgart Digital shows that 35% of European investors would switch to banks with better crypto offerings, but regulatory uncertainty remains an issue.

More News

Market

Bitcoin To $250K? Billionaire Investor Tim Draper Doubles Down On Target

YahooApr 21, 2026

Billionaire venture capitalist Tim Draper is holding on to his ambitious $250,000 target for Bitcoin. "I have reason to believe that Bitcoin will reach $250k in 18 months… and eventually I expect the number to be higher as Bitcoin rises...

← Back to News